New review into teenager's death
AN independent review is to be held into the death of teenager Oliver McGowan.
NHS England announced the new review into Oliver's death at Southmead Hospital after a finding that it was “avoidable” was removed from a previous report.
Oliver, 18, of Emersons Green, died in 2016 after a reaction to an antipsychotic drug, which he was given against his own and his parents’ requests and despite medical records showing he had an intolerance to such medication.
Oliver’s parents Paula and Thomas believe their son would still be alive had he not been given the drug, Olanzapine, which an inquest found had caused his brain to swell.
Industry publication the Health Service Journal reported that emails obtained under freedom of information rules showed the Learning Disabilities Mortality Review into Oliver's death had been changed between its first and final versions, removing a conclusion that the death was avoidable.
The Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group, which is responsible for funding NHS care in the region, has denied altering the report, saying that the panel producing the report was "not able to say categorically" whether Oliver’s death was avoidable.
Oliver's parents welcomed the NHS England decision for a review by independent expert Fiona Ritchie and overseen by Dr Celia Clark.
They said: “We very much hope that we will be listened to throughout this process and that the causes of Oliver’s death will, at last, be fully investigated."